Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.
According to several prospective population-based studies, glycemic control influences the risk for cardiovascular disease, including coronary heart disease, independently of conventional risk factors in patients with type 2 diabetes. Recent clinical trials, particularly the United Kingdom Prospective Diabetes Study, have shown that microvascular complications and macrovascular complications, although to a lesser extent, can be prevented in patients with type 2 diabetes with correction of glycemic control. However, in the treatment and prevention of cardiovascular disease in type 2 diabetes, all known cardiovascular risk factors should be attacked simultaneously.
Laakso
M
M
Professor and Chair, Department of Medicine, Univeristy of Kuopio, Kuopio, Finland. markku.laakso@uku.fi
D001786:Blood Glucose / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000628:therapy; D012307:Risk Factors
D001786:Blood Glucose